Welcome to the Erin Andra Wilson Update Web Page.
This site will provide frequent updates on Erin's progress
in her renewed fight against leukemia. Please bookmark
this page and check back for updates on Erin's progress.
We also invite you to peruse the Archives to
view past updates and pictures regarding Erin's journey.
We do not intend for this website to be the sole means
of communicating Erin's progress with family and friends.
We welcome and appreciate phone calls, cards, letters
with her sisters, Emily and Rachel
Isla Mujeres, Mexico -- July 2000.
Erin was diagnosed on October 20, 1994, at the age of four, with
Acute Lymphocytic Leukemia.
After approximately one year of chemotherapy, Erin suffered a relapse in September 1995.
In response to the relapse, Erin's chemotherapy was adjusted to a more aggressive and
Erin did very well on the new regimen, successfully completing four years of chemotherapy
in October 1998 without a relapse. For almost three years after completing treatment,
Erin continued to do well until July 16, 2001, when a routine blood test revealed a relapse
of her leukemia. As a result of this relapse, Erin underwent a
bone marrow transplant on
November 21, 2001 at the Fred Hutchinson Cancer Research Center
in Seattle, Washington.
Erin initially did very well post-transplant, exhibiting very few signs and symptoms of
graft-versus-host disease. Unfortunately, Erin relapsed again on February 25, 2002 just prior
to discharge from the Hutchinson Center. Erin returned immediately to Kansas City and began
treatment under a standard chemotherapy regimen in an attempt to once again induce remission.
The chemotherapy failed. Thus, on April 1, 2002 Erin traveled to Houston, Texas to participate
in a Phase I clinical trial at the MD Anderson Cancer Center
of a new anti-cancer drug called clofarex.
Erin's treatment in Houston induced remission and, after six difficult weeks,
Erin returned home to Kansas City where she underwent a second bone marrow transplant at
Children's Mercy Hospital on July 13, 2002.